QA 1_RFQ 19AL6027Q0001.docx
DOCX document 31 KB Posted
- Solicitation number
- 19AL6027Q0001
- Issued by
-
Department of State
About this file
This is a Questions and Answers document from the first Q&A session for RFQ 19AL6027Q0001, issued by the Embassy of the United States of America on November 19, 2026, regarding a Portable Handheld NIR Analyzer for Cannabis and Drug Screening for the Drug Laboratory of the Albanian State Police.
The document addresses two key clarifications from potential vendors. First, regarding samples required for acceptance testing of non-cannabis drug models, the government clarified that vendors are not expected to provide actual narcotics (cocaine, methamphetamine, MDMA, etc.). Instead, suppliers must submit independent validation documentation demonstrating how their proposed models perform against appropriate reference methods and provide support to the laboratory during the acceptance testing phase once equipment is received. Second, concerning the requirement for an authorized EU or Balkan service provider, the government confirmed that direct support from the Original Equipment Manufacturer (OEM) may be accepted as an alternative, subject to review and approval. The OEM must provide detailed explanation of service arrangements including repair processes, expected turnaround times, availability of temporary replacement units, and confirmation that parts, labor, and warranty-related shipping to and from Albania are covered under the two-year hardware warranty from final acceptance. The document indicates that a European-based sales representative may coordinate support, provided the OEM's service responsibilities are clearly outlined.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| RFQ_19AL6027Q0001 - Portable Handheld NIR Analyzer.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Embassy of the United States of America
November 19, 2026
Q&A Session 1 – RFQ 19AL6027Q0001
Question 1: The SOW mentions the provision of samples for each mandatory non-cannabis drug model. Can you specify exactly what is being requested? Is the expectation for us to provide actual samples of narcotics such as cocaine, meth, mdma, etc?
Answer 1: Samples for acceptance testing
The vendor is not expected to provide narcotics. Instead, the supplier should submit independent validation documentation demonstrating how the proposed models perform against appropriate reference methods and, if necessary, provide support to the laboratory during acceptance testing phase once the equipment is received.
Question 2: Can you clarify the requirement of an authorized EU or Balkan service provider? The OEM has a sales rep located in a European country, but this is not a service provider. Typically, if an end user has issues with a system, they are asked to ship the defective system back to the OEM for repairs (if necessary) and a temporary replacement would be provided in the meantime. Would this be accepted?
Answer 2: Service and repair arrangements
Direct support from the OEM may be accepted in place of an authorized EU/Balkan service provider, subject to review and approval. Please explain how this arrangement would work, including the repair process, expected turnaround times, whether a temporary replacement unit would be available, and confirmation that parts, labor, and warranty-related shipping to and from Albania are covered under the two-year hardware warranty from the date of final acceptance. The European-based sales representative may coordinate support, as long as the OEM's service responsibilities are clearly outlined.
image1.png oleObject1.bin
File details come from the government source that posted it. Updated .